The abstract is read at the publisher; the summary is JClub's.
Myeloid CD36 deficiency in fibrotic mouse livers promotes macrophage adaptive immunity, linked to restored MHC-I antigen presentation and CD8+ T cell activation.
- Why it matters: Hepatic fibrosis lacks effective prevention and therapy, and macrophage lipid handling is implicated in how immune function shapes fibrosis progression.
- What they did: Macrophages took up stellate-cell–secreted lipids via CD36, increasing lipid peroxidation and ferroptosis while reducing antigen presentation; CD36 loss activated cGAS-STING and upregulated MHC-I programs by single-cell RNA sequencing.
- The result: Macrophage-specific CD36 knockout protected mice from fibrosis progression, and in cirrhosis patients CD36 expression was elevated, supporting CD36 as a therapeutic target.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.